-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Initiates Coverage On Atossa Therapeutics with Buy Rating, Announces Price Target of $4

Benzinga·06/05/2025 17:15:59
Listen to the news
Craig-Hallum analyst Albert Lowe initiates coverage on Atossa Therapeutics (NASDAQ:ATOS) with a Buy rating and announces Price Target of $4.